Octapharma Ab
Plant certified by the Brazilian health regulator (ANVISA)
ANVISA, the Brazilian health regulator, holds a valid Good Manufacturing Practice certificate for this plant, covering biological active pharmaceutical ingredients, valid until 2027-11-20. The certificate is issued after an inspection of the plant itself, which is why a foreign regulator names this site: goods made here are allowed on the Brazilian market. Process number 25351544837201689.
- Type
- Manufacturer
- Location
- Sweden
- Categories
- फार्मास्युटिकल विनिर्माण
- Markets
- स्वीडन, ब्राज़ील
Listed in a source registry
Verified facts
- debarment-clear (green), checked 2026-08-24 OpenSanctions
- sanctions-clear (green), checked 2026-08-24 OpenSanctions
- market-access-eu (green), checked 2026-08-22 TRACES NT, European Commission register of approved establishments (DG SANTE)
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- places-goods-on-market (green), checked 2026-08-23 Finnish Medicines Agency (Fimea), basic register of medicinal products
- registered-manufacturer (green), checked 2026-08-21 Jordan Food and Drug Administration (JFDA), approved manufacturing sites (open data portal of Jordan)
- lei-active (green), checked 2026-08-23 GLEIF global LEI register (golden copy)
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)